Delivery Order SPE2DB24D3015-SPE2DB25FFZHY

Award Date 5/12/25
Potential Completion Date 5/13/25
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price of $11,362.20 and a completion date of December 5, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite...
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 16, 2024, with a ceiling value of $1,879.98 and a completion date of December 17, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a...
The federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,222.62 and is a Firm Fixed Price Delivery Order with a completion date of May 22, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a prescription medication, to the Defense Logistics Agency (DLA). The $54,094.26 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 12, 2025, with an ultimate completion date of May 13, 2025. The contract is not set aside and was competed openly. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. This is a firm fixed price delivery order contract with a ceiling value of $15,781.48 and a period of performance through March 20, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,253.32 and is a firm-fixed-price delivery order with a completion date of May 9, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set-aside and represents an open competition award. Amerisourcebergen Drug Corp also...
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $166,908.98 and is a firm fixed-price delivery order contract. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML to the Defense Logistics Agency (DLA), a defense agency. The $5,978.36 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through November 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,593.82 and is a firm fixed price delivery order with an ultimate completion date of August 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,840.89 and a completion date of December 13, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFZHY
    Delivery Order

This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $7,766.37 and is a firm fixed-price delivery order with a completion date of May 13, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set-aside and was awarded on May 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/17/25, 1:05 AM